典型文献
Research progress on immune checkpoint inhibitors in neoadjuvant therapy for gastric cancer
文献摘要：
In recent years, immune checkpoint inhibitors (ICIs) have become an important treatment strategy for advanced gastric cancer. Immunotherapy has gradually transitioned from a later-line to a first-line treatment for advanced gastric cancer. Simultaneously, more and more researchers have begun to pay attention to whether immunotherapy can be used for resectable gastric cancer. The current use of ICIs in the neoadjuvant treatment of gastric cancer is still in its exploratory stage, with a number of clinical trials currently underway. However, the available data show good application prospects. This article reviewsthe research progress on ICIs in the neoadjuvant therapy for gastric cancer and evokes some unresolved problems.
文献关键词：
中图分类号：
作者姓名：
Wenting Li;Shiying Yu
作者机构：
Department of Oncology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
文献出处：
引用格式：
[1]Wenting Li;Shiying Yu-.Research progress on immune checkpoint inhibitors in neoadjuvant therapy for gastric cancer)[J].肿瘤学与转化医学（英文）,2022(02):74-82
A类：
reviewsthe
B类：
Research,progress,immune,checkpoint,inhibitors,neoadjuvant,gastric,cancer,In,recent,years,ICIs,have,become,important,treatment,strategy,advanced,Immunotherapy,has,gradually,transitioned,from,later,line,first,Simultaneously,more,researchers,begun,pay,attention,whether,immunotherapy,used,resectable,still,its,exploratory,stage,number,clinical,trials,currently,underway,However,available,data,show,good,application,prospects,This,article,evokes,some,unresolved,problems
AB值：
0.569459
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
